Annual FCF
-$145.66 M
-$28.45 M-24.27%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual free cash flow is -$145.66 million, with the most recent change of -$28.45 million (-24.27%) on December 31, 2023.
- During the last 3 years, AXSM annual FCF has fallen by -$67.16 million (-85.55%).
- AXSM annual FCF is now -8830.29% below its all-time high of -$1.63 million, reached on December 31, 2013.
Performance
AXSM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$18.72 M
+$11.44 M+37.93%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly free cash flow is -$18.72 million, with the most recent change of +$11.44 million (+37.93%) on September 30, 2024.
- Over the past year, AXSM quarterly FCF has increased by +$11.65 million (+38.35%).
- AXSM quarterly FCF is now -1501.32% below its all-time high of -$1.17 million, reached on March 31, 2015.
Performance
AXSM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$132.82 M
+$35.20 M+20.95%
September 30, 2024
Summary
- As of February 7, 2025, AXSM TTM free cash flow is -$132.82 million, with the most recent change of +$35.20 million (+20.95%) on September 30, 2024.
- Over the past year, AXSM TTM FCF has increased by +$12.85 million (+8.82%).
- AXSM TTM FCF is now -11260.62% below its all-time high of -$1.17 million, reached on March 31, 2015.
Performance
AXSM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AXSM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.3% | +38.4% | +8.8% |
| 3 y3 years | -85.5% | +30.8% | -32.5% |
| 5 y5 years | -384.1% | -76.1% | -186.3% |
AXSM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.2% | at low | -217.7% | +66.3% | -47.2% | +31.3% |
| 5 y | 5-year | -214.0% | at low | -217.7% | +66.3% | -186.3% | +31.3% |
| alltime | all time | -8830.3% | at low | -1501.3% | +66.3% | <-9999.0% | +31.3% |
Axsome Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.72 M(-37.9%) | -$132.82 M(-20.9%) |
| Jun 2024 | - | -$30.16 M(-43.7%) | -$168.01 M(-13.1%) |
| Mar 2024 | - | -$53.56 M(+76.4%) | -$193.34 M(+32.7%) |
| Dec 2023 | -$145.66 M(+24.3%) | -$30.37 M(-43.7%) | -$145.66 M(+1.8%) |
| Sep 2023 | - | -$53.92 M(-2.8%) | -$143.04 M(+27.8%) |
| Jun 2023 | - | -$55.48 M(+841.6%) | -$111.94 M(+24.1%) |
| Mar 2023 | - | -$5.89 M(-78.8%) | -$90.24 M(-23.0%) |
| Dec 2022 | -$117.21 M(+8.0%) | -$27.74 M(+21.6%) | -$117.21 M(-0.9%) |
| Sep 2022 | - | -$22.82 M(-32.4%) | -$118.31 M(-3.4%) |
| Jun 2022 | - | -$33.78 M(+2.8%) | -$122.52 M(+7.3%) |
| Mar 2022 | - | -$32.87 M(+14.0%) | -$114.16 M(+5.2%) |
| Dec 2021 | -$108.53 M(+38.3%) | -$28.84 M(+6.7%) | -$108.53 M(+8.2%) |
| Sep 2021 | - | -$27.03 M(+6.4%) | -$100.27 M(+12.7%) |
| Jun 2021 | - | -$25.41 M(-6.7%) | -$88.98 M(+7.9%) |
| Mar 2021 | - | -$27.25 M(+32.4%) | -$82.47 M(+5.0%) |
| Dec 2020 | -$78.50 M(+69.2%) | -$20.57 M(+30.6%) | -$78.50 M(+4.0%) |
| Sep 2020 | - | -$15.75 M(-16.7%) | -$75.50 M(+7.3%) |
| Jun 2020 | - | -$18.90 M(-18.8%) | -$70.38 M(+17.0%) |
| Mar 2020 | - | -$23.28 M(+32.5%) | -$60.17 M(+29.7%) |
| Dec 2019 | -$46.39 M | -$17.57 M(+65.3%) | -$46.39 M(+20.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$10.63 M(+22.3%) | -$38.62 M(+13.9%) |
| Jun 2019 | - | -$8.69 M(-8.5%) | -$33.91 M(+3.1%) |
| Mar 2019 | - | -$9.50 M(-3.0%) | -$32.89 M(+9.3%) |
| Dec 2018 | -$30.09 M(+13.6%) | -$9.79 M(+65.4%) | -$30.09 M(+13.2%) |
| Sep 2018 | - | -$5.92 M(-22.9%) | -$26.58 M(-2.0%) |
| Jun 2018 | - | -$7.68 M(+14.7%) | -$27.11 M(+2.2%) |
| Mar 2018 | - | -$6.70 M(+6.4%) | -$26.54 M(+0.2%) |
| Dec 2017 | -$26.48 M(+23.8%) | -$6.29 M(-2.5%) | -$26.48 M(-3.4%) |
| Sep 2017 | - | -$6.45 M(-9.1%) | -$27.41 M(+6.1%) |
| Jun 2017 | - | -$7.10 M(+6.9%) | -$25.84 M(+7.4%) |
| Mar 2017 | - | -$6.64 M(-8.1%) | -$24.07 M(+12.5%) |
| Dec 2016 | -$21.39 M(+186.7%) | -$7.22 M(+48.0%) | -$21.39 M(+30.3%) |
| Sep 2016 | - | -$4.88 M(-8.4%) | -$16.42 M(+21.9%) |
| Jun 2016 | - | -$5.33 M(+34.6%) | -$13.47 M(+31.4%) |
| Mar 2016 | - | -$3.96 M(+75.5%) | -$10.25 M(+37.4%) |
| Dec 2015 | -$7.46 M(+62.3%) | -$2.25 M(+17.0%) | -$7.46 M(+43.3%) |
| Sep 2015 | - | -$1.93 M(-8.6%) | -$5.20 M(+58.8%) |
| Jun 2015 | - | -$2.11 M(+80.3%) | -$3.28 M(+180.3%) |
| Mar 2015 | - | -$1.17 M | -$1.17 M |
| Dec 2014 | -$4.60 M(+181.8%) | - | - |
| Dec 2013 | -$1.63 M | - | - |
FAQ
- What is Axsome Therapeutics annual free cash flow?
- What is the all time high annual FCF for Axsome Therapeutics?
- What is Axsome Therapeutics annual FCF year-on-year change?
- What is Axsome Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly FCF year-on-year change?
- What is Axsome Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Axsome Therapeutics?
- What is Axsome Therapeutics TTM FCF year-on-year change?
What is Axsome Therapeutics annual free cash flow?
The current annual FCF of AXSM is -$145.66 M
What is the all time high annual FCF for Axsome Therapeutics?
Axsome Therapeutics all-time high annual free cash flow is -$1.63 M
What is Axsome Therapeutics annual FCF year-on-year change?
Over the past year, AXSM annual free cash flow has changed by -$28.45 M (-24.27%)
What is Axsome Therapeutics quarterly free cash flow?
The current quarterly FCF of AXSM is -$18.72 M
What is the all time high quarterly FCF for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly free cash flow is -$1.17 M
What is Axsome Therapeutics quarterly FCF year-on-year change?
Over the past year, AXSM quarterly free cash flow has changed by +$11.65 M (+38.35%)
What is Axsome Therapeutics TTM free cash flow?
The current TTM FCF of AXSM is -$132.82 M
What is the all time high TTM FCF for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM free cash flow is -$1.17 M
What is Axsome Therapeutics TTM FCF year-on-year change?
Over the past year, AXSM TTM free cash flow has changed by +$12.85 M (+8.82%)